Cheng‐Kun Wu

970 total citations
57 papers, 662 citations indexed

About

Cheng‐Kun Wu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Cheng‐Kun Wu has authored 57 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 29 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Cheng‐Kun Wu's work include Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (16 papers) and Hepatitis C virus research (14 papers). Cheng‐Kun Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (16 papers) and Hepatitis C virus research (14 papers). Cheng‐Kun Wu collaborates with scholars based in Taiwan, China and United States. Cheng‐Kun Wu's co-authors include Seng‐Kee Chuah, Wei‐Chen Tai, Chih‐Ming Liang, Tsung‐Hui Hu, Shih‐Cheng Yang, Ming‐Tsung Lin, Chien‐Ning Hsu, Ming‐Chao Tsai, Yuan‐Hung Kuo and Kuo‐Chin Chang and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Environmental Research and Public Health.

In The Last Decade

Cheng‐Kun Wu

52 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng‐Kun Wu Taiwan	15	302	281	273	121	99	57	662
A. Merighi Italy	12	178 0.6×	148 0.5×	344 1.3×	210 1.7×	107 1.1×	38	676
Yuan‐Hung Kuo Taiwan	22	634 2.1×	706 2.5×	407 1.5×	141 1.2×	176 1.8×	83	1.3k
Kuo‐Chih Tseng Taiwan	16	443 1.5×	456 1.6×	188 0.7×	35 0.3×	161 1.6×	89	842
Chih‐Ming Liang Taiwan	17	120 0.4×	81 0.3×	539 2.0×	246 2.0×	206 2.1×	65	771
Hyoung Su Kim South Korea	15	375 1.2×	333 1.2×	183 0.7×	46 0.4×	88 0.9×	46	643
Theodor Voiosu Romania	16	240 0.8×	184 0.7×	270 1.0×	65 0.5×	180 1.8×	74	640
Shih‐Cheng Yang Taiwan	12	111 0.4×	105 0.4×	266 1.0×	121 1.0×	74 0.7×	36	402
R Chapman United Kingdom	17	432 1.4×	586 2.1×	549 2.0×	172 1.4×	243 2.5×	30	1.1k
Amanda Vestito Italy	17	310 1.0×	275 1.0×	518 1.9×	280 2.3×	166 1.7×	41	911
Kyu Sung Rim South Korea	19	668 2.2×	664 2.4×	167 0.6×	51 0.4×	102 1.0×	45	1.1k

Countries citing papers authored by Cheng‐Kun Wu

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Kun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Kun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Kun Wu more than expected).

Fields of papers citing papers by Cheng‐Kun Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Kun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Kun Wu. The network helps show where Cheng‐Kun Wu may publish in the future.

Co-authorship network of co-authors of Cheng‐Kun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Kun Wu. A scholar is included among the top collaborators of Cheng‐Kun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Kun Wu. Cheng‐Kun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yap, Desmond Y. H., Cheng‐Kun Wu, Colin Tang, et al.. (2025). A long term bone and renal safety of TAF treatment on renal transplant recipients. Biomedical Journal. 48(6). 100833–100833.

Tai, Wei‐Chen, Pao‐Yuan Huang, Chih‐Chien Yao, et al.. (2024). The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan. Journal of Microbiology Immunology and Infection. 57(4). 601–608. 2 indexed citations

Tai, Wei‐Chen, Chih‐Ming Liang, Cheng‐Kun Wu, et al.. (2024). Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease. Journal of Microbiology Immunology and Infection. 58(1). 62–69. 37 indexed citations

Liang, Chih‐Ming, Yi‐Chun Chiu, Lung‐Sheng Lu, et al.. (2022). Early and Direct Endoscopic Stone Removal in the Moderate Grade of Acute Cholangitis with Choledocholithiasis Was Safe and Effective: A Prospective Study. Life. 12(12). 2000–2000. 2 indexed citations

Wu, Cheng‐Kun, Chien‐Ning Hsu, Shih‐Cheng Yang, et al.. (2021). Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis. Infection and Drug Resistance. Volume 14. 2121–2131. 4 indexed citations

Yao, Chih‐Chien, Chung‐Mou Kuo, Chien‐Ning Hsu, et al.. (2019). <p>First-line <em>Helicobacter pylori</em> eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus</p>. Infection and Drug Resistance. Volume 12. 1425–1431. 17 indexed citations

Liang, Chih‐Ming, Shih‐Cheng Yang, Cheng‐Kun Wu, et al.. (2019). Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs. Journal of Clinical Medicine. 8(10). 1722–1722. 8 indexed citations

Yen, Yi‐Hao, Pao‐Yuan Huang, Chih‐Che Lin, et al.. (2019). The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection. Gastroenterology Research and Practice. 2019. 1–9. 3 indexed citations

Wu, Cheng‐Kun, Shih‐Cheng Yang, Yuchi Li, et al.. (2019). The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. Journal of Gastroenterology and Hepatology. 35(5). 777–787. 8 indexed citations

10.

Liang, Chih‐Ming, Chung‐Mou Kuo, Lung‐Sheng Lu, et al.. (2019). A comparison between non-sedation and general endotracheal anesthesia for retrograde endoscopic common bile duct stone removal: A tertiary center experience. Biomedical Journal. 42(2). 131–136. 5 indexed citations

11.

Wu, Cheng‐Kun, Chih‐Ming Liang, Wei‐Chen Tai, et al.. (2018). Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan. International Journal of Environmental Research and Public Health. 15(12). 2655–2655. 13 indexed citations

12.

Chuah, Seng‐Kee, Shih‐Cheng Yang, Chih‐Ming Liang, et al.. (2018). Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis. PLoS ONE. 13(5). e0197127–e0197127. 15 indexed citations

13.

Wang, Jiunn‐Wei, Chien‐Ning Hsu, Chih‐Ming Liang, et al.. (2018). Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS ONE. 13(1). e0190219–e0190219. 29 indexed citations

14.

Yen, Yi‐Hao, Ming‐Tsung Lin, Fang‐Ying Kuo, et al.. (2017). The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients. Liver International. 38(6). 1064–1073. 14 indexed citations

15.

Hu, Tsung‐Hui, Kuo‐Chin Chang, Po‐Lin Tseng, et al.. (2017). Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy. Medicine. 96(46). e8696–e8696. 9 indexed citations

16.

Yen, Yi‐Hao, Jung‐Fu Chen, Cheng‐Kun Wu, et al.. (2017). The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice. Journal of the Formosan Medical Association. 116(11). 852–861. 10 indexed citations

17.

Yen, Yi‐Hao, Kuo‐Chin Chang, Ming‐Chao Tsai, et al.. (2017). Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease. Journal of the Formosan Medical Association. 117(4). 268–275. 17 indexed citations

18.

Wu, Cheng‐Kun, Hon‐Yi Shi, Wei‐Chen Tai, et al.. (2016). Medical expenses in treating acute esophageal variceal bleeding. Medicine. 95(28). e4215–e4215. 10 indexed citations

19.

Wu, Cheng‐Kun, Kuo‐Chin Chang, Chao‐Hung Hung, et al.. (2016). Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy. Journal of Antimicrobial Chemotherapy. 71(7). 1943–1947. 20 indexed citations

20.

Hung, Chien‐Hui, Chien‐Hung Chen, C.‐M. Lee, et al.. (2007). Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma. Journal of Viral Hepatitis. 15(1). 58–65. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact